ketanserin has been researched along with substance p in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (16.67) | 18.7374 |
1990's | 9 (50.00) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 1 (5.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Descarries, L; Paré, M; Quirion, R | 1 |
Adelstein, RS; Corson, MA; Schoenberg, M; Sellers, JR | 1 |
Ahlman, H; Dahlström, A; Lidberg, P | 1 |
Ahlman, H; Dahlström, A; Grönstad, K; Jaffe, BM; Nilsson, O; Oberg, K | 1 |
Ahlman, H; Dahlström, A; Grönstad, K; Jaffe, BM; Oberg, K; Tisell, LE; Zinner, MJ | 1 |
Fernández, AG; Fernández, E; Goñalons, E; Martín, MT | 1 |
Ohkubo, Y; Takeshita, N; Yamaguchi, I | 1 |
Kurihara, T; Otsuka, M; Yoshioka, K | 1 |
Bax, WA; Bos, E; Renzenbrink, GJ; Saxena, PR; Thijssen, EJ; Van Heuven-Nolsen, D | 1 |
Benjamin, M; Perdue, MH; Savedia, S; Wang, L | 1 |
Cenarruzabeitia, E; Del Rio, J; Lasheras, B; Ramírez, MJ | 1 |
Bischoff, A; Diener, H; Fetscher, C; Limmroth, V; Michel, MC; Wermelskirchen, D | 1 |
Bakker, EN; Spaan, JA; van Der Meulen, ET; VanBavel, E | 1 |
Yonehara, N | 1 |
Peña, F; Ramirez, JM; Tryba, AK | 1 |
Hiyama, Y; Ishimura, M; Kataoka, S; Maeda, T; Suda, M | 1 |
Leung, SW; Man, RY; Ng, KF; Vanhoutte, PM | 1 |
Ganev, EG; Hiruma-Lima, CA; Martins, DF; Mazzardo-Martins, L; Nishijima, CM; Rocha, LR; Santos, AR | 1 |
18 other study(ies) available for ketanserin and substance p
Article | Year |
---|---|
Up-regulation of 5-hydroxytryptamine2 and neurokinin-1 receptors associated with serotonin/substance P hyperinnervation in the rat inferior olive.
Topics: Animals; Autoradiography; Iodine Radioisotopes; Ketanserin; Olivary Nucleus; Organ Specificity; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin; Substance P; Tritium; Up-Regulation | 1992 |
Substance P contracts bovine tracheal smooth muscle via activation of myosin light chain kinase.
Topics: Animals; Atropine; Calcium; Cattle; Enzyme Activation; Glycopeptides; In Vitro Techniques; Indomethacin; Ketanserin; Kinetics; Masoprocol; Muscle Contraction; Muscle, Smooth; Myosin Subfragments; Myosin-Light-Chain Kinase; Peptide Mapping; Phosphorylation; Potassium Chloride; Prazosin; Propranolol; Pyrilamine; Substance P; Trachea | 1990 |
On the nature of the contractile motor responses of the rat stomach elicited by serotonin or substance P in vitro.
Topics: Animals; Atropine; Hexamethonium; Hexamethonium Compounds; In Vitro Techniques; Ketanserin; Male; Muscle Contraction; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Stomach; Substance P; Tachyphylaxis; Tetrodotoxin | 1985 |
The pentagastrin test in the diagnosis of the carcinoid syndrome.
Topics: Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Hydroxyindoleacetic Acid; Ketanserin; Male; Malignant Carcinoid Syndrome; Pentagastrin; Piperidines; Receptors, Serotonin; Serotonin Antagonists; Substance P; Time Factors | 1985 |
The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin.
Topics: Aged; Calcium; Digestive System; Female; Humans; Ketanserin; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Middle Aged; Pentagastrin; Piperidines; Serotonin; Serotonin Antagonists; Substance P; Vasomotor System | 1985 |
Mechanisms mediating the effects of cholecystokinin on avian small intestine longitudinal smooth muscle.
Topics: Acetylcholine; Amino Acid Sequence; Analysis of Variance; Animals; Chickens; Cholecystokinin; Dose-Response Relationship, Drug; Ileum; In Vitro Techniques; Ketanserin; Male; Mammals; Methiothepin; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth; Neurons; Peptide Fragments; Receptors, Cholecystokinin; Receptors, Neurokinin-1; Sincalide; Structure-Activity Relationship; Substance P; Tetragastrin | 1994 |
Tiapride attenuates pain transmission through an indirect activation of central serotonergic mechanism.
Topics: Animals; Central Nervous System; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dopamine Antagonists; Female; Fenclonine; Indoles; Injections, Spinal; Ketanserin; Male; Mice; Nociceptors; Pain; Pain Measurement; Pindolol; Serotonin; Serotonin Antagonists; Somatostatin; Substance P; Synaptic Transmission; Tiapamil Hydrochloride; Tropisetron | 1995 |
Tachykininergic slow depolarization of motoneurones evoked by descending fibres in the neonatal rat spinal cord.
Topics: 5,7-Dihydroxytryptamine; Animals; Animals, Newborn; Excitatory Amino Acid Antagonists; In Vitro Techniques; Ketanserin; Motor Neurons; Neurokinin A; Rats; Rats, Wistar; Spinal Nerve Roots; Substance P; Synaptic Transmission; Tachykinins; Thiorphan; Thyrotropin-Releasing Hormone | 1995 |
5-HT receptors mediating contractions of the isolated human coronary artery.
Topics: Adolescent; Adult; Arteries; Blood Platelets; Child; Child, Preschool; Coronary Vessels; Dose-Response Relationship, Drug; Ergotamine; Female; Humans; In Vitro Techniques; Infant; Ketanserin; Male; Metergoline; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Pindolol; Potassium; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance P; Sumatriptan; Yohimbine | 1993 |
The role of mast cells in intestinal immunophysiology.
Topics: Animals; Cholera Toxin; Cyclooxygenase Inhibitors; Diphenhydramine; Histamine H1 Antagonists; Immunoglobulin E; Immunologic Deficiency Syndromes; Intestinal Mucosa; Intestines; Ketanserin; Mast Cells; Mice; Mice, Mutant Strains; Myenteric Plexus; Ovalbumin; Piroxicam; Serotonin Antagonists; Stem Cell Factor; Submucous Plexus; Substance P; Tetrodotoxin | 1995 |
5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Benzazepines; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Ergolines; Haloperidol; In Vitro Techniques; Ketanserin; Male; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Physalaemin; Potassium; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Substance P | 1997 |
Effects of alniditan on neurogenic oedema in the rat dura mater and on contraction of rat basilar artery.
Topics: Animals; Basilar Artery; Benzopyrans; Brain Edema; Capillary Permeability; Dose-Response Relationship, Drug; Dura Mater; Extravasation of Diagnostic and Therapeutic Materials; In Vitro Techniques; Ketanserin; Male; Oxadiazoles; Piperazines; Propylamines; Pyrimidines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Antagonists; Substance P; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling.
Topics: Acetylcholine; Albumins; Animals; Antihypertensive Agents; Blood Pressure; Catheterization; Endothelium, Vascular; Fetal Proteins; Free Radical Scavengers; Hot Temperature; Ketanserin; Losartan; Male; Microscopy, Electron; Muscle, Smooth, Vascular; Organ Culture Techniques; Rats; Rats, Wistar; Serotonin; Substance P; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2000 |
Influence of serotonin receptor antagonists on substance P and serotonin release evoked by tooth pulp stimulation with electro-acupuncture in the trigeminal nucleus cudalis of the rabbit.
Topics: Afferent Pathways; Animals; Dental Pulp Cavity; Electric Stimulation; Electroacupuncture; Indoles; Ketanserin; Male; Neurons; Nociceptors; Pain; Pain Management; Piperazines; Rabbits; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Substance P; Trigeminal Caudal Nucleus; Tropisetron | 2001 |
Gasping activity in vitro: a rhythm dependent on 5-HT2A receptors.
Topics: Action Potentials; Analysis of Variance; Animals; Animals, Newborn; Biological Clocks; Dose-Response Relationship, Drug; Drug Interactions; Flufenamic Acid; In Vitro Techniques; Ketanserin; Mice; Nerve Net; Neurons; Oxygen; Patch-Clamp Techniques; Piperidines; Receptor, Serotonin, 5-HT2A; Respiratory Burst; Respiratory Center; Respiratory Mechanics; Serotonin Antagonists; Substance P; Synaptic Transmission; Time Factors | 2006 |
Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Acetylcholine; Albuterol; Animals; Atropine; Benzoquinones; Carbachol; Chromones; Cyclopropanes; Dinoprost; Drug Evaluation, Preclinical; Guinea Pigs; Heptanoic Acids; Histamine; In Vitro Techniques; Indoles; Indomethacin; Ketanserin; Ketotifen; Leukotriene Antagonists; Leukotriene D4; Male; Muscle Contraction; Muscle, Smooth; Phenylcarbamates; Powders; Procaterol; Prostaglandin Antagonists; Prostaglandin D2; Quinolines; Receptors, Thromboxane A2, Prostaglandin H2; Serotonin; Substance P; Sulfides; Sulfonamides; Tosyl Compounds; Trachea; Tryptophan | 2006 |
Endothelium-derived hyperpolarizing factor mediated relaxations in pig coronary arteries do not involve Gi/o proteins.
Topics: Animals; Apamin; Biological Factors; Bradykinin; Calcimycin; Charybdotoxin; Coronary Vessels; Dinoprost; Dose-Response Relationship, Drug; Endothelium-Dependent Relaxing Factors; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, Gi-Go; Hemostatics; Ionophores; Ketanserin; Muscle Relaxation; Neurotoxins; Neurotransmitter Agents; NG-Nitroarginine Methyl Ester; Peptide Fragments; Pertussis Toxin; Serotonin; Serotonin Antagonists; Substance P; Sus scrofa; Thrombin; Vasodilator Agents | 2008 |
Citral: a monoterpene with prophylactic and therapeutic anti-nociceptive effects in experimental models of acute and chronic pain.
Topics: Acute Pain; Acyclic Monoterpenes; Analgesics; Animals; Capsaicin; Chronic Pain; Excitatory Amino Acids; Formaldehyde; Glutamic Acid; Hyperalgesia; Ischemia; Ketanserin; Male; Mice; Monoterpenes; Neuralgia; Pain, Postoperative; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Stomach Ulcer; Substance P; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2014 |